Screening for Neurodevelopmental Disorders in Japanese 18- and 36-Month Health Check-Ups: Utility and Reproducibility of the ESSENCE-Q - Report - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Evaluation of the ESSENCE-Q for Identifying Neurodevelopmental Disorders During 18- and 36-Month Health Assessments in Japan: Effectiveness and Consistency
Clinical Report: Evaluation of the ESSENCE-Q for Identifying NDDs in Japan
Overview
The ESSENCE-Q has been evaluated for its effectiveness in identifying neurodevelopmental disorders (NDDs) during 18- and 36-month health assessments in Japan.
Background
Neurodevelopmental disorders, including ASD, ADHD, LD, and IDD, affect approximately 10% of the population. Early intervention is crucial, as it can improve outcomes for affected children. The ESSENCE-Q framework offers a comprehensive approach to screening for these disorders during routine health check-ups.
Data Highlights
No specific numerical data provided in the source material.
Key Findings
The ESSENCE-Q is designed to assess a broad range of developmental domains.
Validation studies have shown the feasibility of incorporating the ESSENCE-Q into routine health check-ups.
Early identification of neurodevelopmental red flags is possible at 18 and 36 months.
Screening results should be interpreted as indicators of current developmental status.
Professionals conducting screenings must be competent to ensure accurate assessments.
Clinical Implications
Incorporating the ESSENCE-Q into health check-ups can facilitate early identification of neurodevelopmental disorders.
Conclusion
The ESSENCE-Q is a tool for early detection of neurodevelopmental disorders in Japan.
Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.